Sharon Benzeno

Sharon Benzeno

Corporate Officer/Principal at ADAPTIVE BIOTECHNOLOGIES CORPORATION

Net worth: 5 M $ as of 2026-07-30

52 year
Consumer Services
Health Technology
Technology Services

Profile

Sharon Benzeno is currently Chief Commercial Officer-Immune Medicine at Adaptive Biotechnologies Corp.
since 2022, with employment at the company starting in 2014.
Former positions include Senior Director at Elsevier, Inc. from 2013 to 2014, Senior Manager-Oncology Business at Capgemini SE from 2011 to 2013, and Senior Scientific Manager at AstraZeneca PLC from 2005 to 2011.
Education includes undergraduate studies at New York University, an MBA from The Leonard N Stern School of Business, and a doctorate from New York University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-28 221,278 ( 0.14% ) 5 M $ 2026-07-30

Sharon Benzeno active positions

CompaniesPositionStart
ADAPTIVE BIOTECHNOLOGIES CORPORATION Corporate Officer/Principal 2018-01-31

Former positions of Sharon Benzeno

CompaniesPositionEnd
Director/Board Member 2014-08-31
CAPGEMINI SE Corporate Officer/Principal 2013-11-30
ASTRAZENECA PLC Corporate Officer/Principal 2011-04-30
See the detail of Sharon Benzeno's experience

Training of Sharon Benzeno

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

65

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Technology Services

Technology Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Sharon Benzeno